OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trial
Titel:
OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trial
Auteur:
Kapoor, Prashant Schmidt, Timothy Jacobus, Susanna Wei, Zihan Fonseca, Rafael Callander, Natalie S. Lonial, Sagar Rajkumar, S. Vincent Kumar, Shaji